BCHT(SH:688276) Xin Lang Cai Jing·2025-09-04 07:36Group 1 - The core point of the news is that Baike Biotechnology has experienced a continuous decline in its stock price, dropping 1.35% on September 4, with a total market value of 9.365 billion yuan and an accumulated decline of 10.69% over the past eight days [1] - Baike Biotechnology, established on March 4, 2004, and listed on June 25, 2021, is primarily engaged in the research, production, and sales of human vaccines, with 100% of its main business income derived from product sales [1] - The stock turnover rate was reported at 1.00%, with a trading volume of 94.33 million yuan on the day of the report [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) has entered the top ten circulating shareholders of Baike Biotechnology, holding 1.5225 million shares, which accounts for 0.37% of the circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF today is approximately 472,000 yuan, with a total floating loss of 4.1261 million yuan during the eight-day decline [2] - The Southern CSI 1000 ETF was established on September 29, 2016, with a current scale of 64.953 billion yuan, and has achieved a year-to-date return of 22.23% [2]